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Abstract
In the natural cellular environment, nucleic acid biomole-
cules like DNA have biological implications via structural
modiﬁcations and through precise coordination with other
biomolecules in the local environment. Here, we detail the
design of nature-inspired smart biomaterials that are based on
the chemical biology of nucleic acids. N-Methylpyrrole (P) and
N-methylimidazole (I) polyamides (PIPs), sequence-speciﬁc
DNA-binding molecules have been, developed to image spe-
ciﬁc DNA sequences and to alter gene expression inside the
living cells. The self-assembling feature of DNAwas harnessed
to achieve the programmed assembly of nanostructures with
diﬀerent dimensions. Also, the advanced DNA architectures
with well-deﬁned properties allowed the real-time visualiza-
tion of the complicated single-molecule interactions, which
in-turn provided vital intracellular mechanistic information.
The molecular recognition properties of DNA were exploited
to design biologically inspired hybrid catalysts for sustainable
organic synthesis. Our review could serve as a guidebook for
researchers who aim to develop nucleic acid-based synthetic
biomaterials.
1. Introduction
Information is a powerful resource that needs to be managed
to avoid aberrant manifestations and has to be harnessed in a
meticulous manner. In nature, living organisms manage their
biological information remarkably by organizing it in a timely
manner.1 The informational molecule called deoxyribonucleic
acid (DNA) stores and retrieves genetic information at the
right place and time in all living systems. Friedrich Miescher
ﬁrst identiﬁed DNA as nuclein in 1869. In 1953, Watson and
Crick found that DNA in living organisms is found as a pair of
molecules in the shape of a double helix and not as a single
biomolecule.2 Since the discovery of the double-helix structure
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of the DNA, an ever-increasing amount of genetic information
is being generated. Several incurable diseases can now be
understood at the level of molecular DNA.3 Consequently,
genetic-knowledge-based therapeutic strategies for treating
diseases have been gaining attention in the medical ﬁeld.4
Transcription factors (TFs) govern the fate of prokaryotic and
eukaryotic cells by transcribing precisely the biological infor-
mation from DNA to construct cellular components. A mal-
function in the intricate machinery of TFs has been correlated
with a growing number of human diseases.5
Natural TFs have ﬂexible structures and are composed of
three domains: (i) a DNA-binding domain (DBD) that attaches
to speciﬁc enhancer or promoter sequences; (ii) a linker domain
(LD); and (iii) a transcriptional activation domain (TAD) that
contains binding sites for other proteins.6 Therefore, artiﬁcial
transcription factors (ATFs) that restore the expression of genes
that are perturbed in disease are attractive as potential therapies.
The past decade has seen the active development of synthetic
modulators that are capable of transcriptional activation.7
Nevertheless, for eﬀective transcriptional regulation, there is
a demand to develop smart biomaterials, such as DNA-based
ATFs, that mimic the structure of TFs and retain the capacity of
their natural counterparts to partake in intricate gene-regulatory
networks. DNA molecules are packaged into nucleosomes,
which are highly compacted structures in which DNA strands
are wrapped around histones. Two key regulatory processes
govern the “ON” and “OFF” states of gene expression in vivo.
One is related to the base sequences that mediate the binding of
transcription factors to promoter regions. The other is related to
the epigenetic control that results from changes in nucleosome
structure after acetylation, methylation, and other histone modi-
ﬁcations. DNA possesses a considerable conformational ﬂex-
ibility, such as the A-form, Z-form, and G-quadruplex.8 Such
structural changes in DNA often control the transcriptional
status of a cell. This dynamic nature of gene expression com-
plicates the eﬀective transcriptional activation of a gene of
interest. In this regard, there is a need to integrate fragmented
knowledge stemming from various disciplines and devise a
sustainable strategy for eﬃcient gene modulation. This over-
arching goal may be achieved via in-depth analysis of the
major biological mechanisms occurring around local DNA
structures. Such vital mechanistic insights may be gained by
building nano- and meso-sized structures with high precision.
To achieve such a complex feat, the remarkable self-
assembling feature and the precise recognition ability of
DNA should be harnessed to construct desired structures with
biochemical importance. DNA can assemble molecules and
nanomaterials in a programmable manner because of its precise
base-pairing system and programmable linear sequence, which
allow an exclusive association via the use of four bases (A, C,
G, and T) and two base pairs (AT and CG). Double-stranded
DNA also allows the design of predicted structures because of
its well-characterized right-handed helical structure and peri-
odic geometry (the 10­10.5 base pairs per turn and 0.34 nm
distance between neighboring base pairs).9 Modern synthetic
chemistry allows the production of hundreds of diﬀerent DNA
molecules, whereas chemical DNA synthesis processes have an
advantage regarding what is observed in a biological system,
as these technologies allow the incorporation of targeting small
molecules directly and their site-selective introduction into a
DNA strand. DNA may also be altered to encompass diverse
functional molecules, ﬂuorescent molecules, and nanomaterials
and can be biochemically manipulated using modifying en-
zymes, such as DNA ligase, kinases, polymerases, and restric-
tion enzymes. Oligodeoxyribonucleotides represent the primary
class of molecules for the preparation of functional modules
and scaﬀolds and for the placement of functional molecules
and nanomaterials. Functionalized oligonucleotides can be
used in template-directed organic synthesis processes and for
performing unusual chemical reactions.10 DNA­gold nano-
particle conjugates may be used for the sensitive detection of a
target DNA.11 The controlled self-assembly and nanostructure
of DNA bestow unique functionalities, particularly when the
conjugated units are assembled sequentially. The naturally
occurring self-assembly feature of DNA has inspired scientists
to simulate the phenomenon for the construction of functional
materials. As controlled self-assembly may yield important
structures, bottom-up approaches based on self-assembly are
in demand.12 To accomplish this complex feat, a precise control
of programming predesigned structures and the placement of
functional molecules into deﬁned scaﬀolds are needed. More-
over, the intrinsic ﬂexibility of long DNA chains should be
controllable via the incorporation of specially designed struc-
tures to construct informative biomaterials.
Furthermore, DNA is an attractive chiral source for asym-
metric synthesis. Because of its high solubility in water, DNA
is considered suitable for the development of water-compatible
catalysts that induce and control enantioselectivity.13 As an
innovative approach, we integrated DNA nanotechnology, cell
biology, and synthetic organic chemistry techniques to acquire
vital mechanistic information and develop knowledge-based
smart functional biomaterials.
2. Development of Innovative DNA-Based Sequence-
Speciﬁc Small Molecules as Artiﬁcial Genetic Switches
Genomic DNA carries a huge amount of information using
only four nucleobases (bases). Consequently, small molecules
or natural proteins that interact with these bases may alter
signiﬁcantly cellular functions and phenotypes. Accordingly,
the oligopeptide antibiotics netropsin and distamycin A
inhibit nucleic acid synthesis depending on the base com-
position of the template DNA.14 Dickerson et al. solved the
crystal structure of netropsin bound to the nucleotide sequence
d(CGCGAATTCGCG) and proposed that the substitution of
imidazole (I) for pyrrole (P) in netropsin generates a class
of small molecules that can read G/C-containing base se-
quences.15 A DNA minor-groove-binding peptide that reads
the sequence (5¤­(A, T)GCGC(A, T)­3¤) suggested the forma-
tion of a 2:1 positively cooperative complex with a four-ligand
(IPPI). Aliphatic/aromatic amino acid pairings facilitated the
design of hairpin polyamides with a wider and more diverse
sequence-recognition ability, and NMR studies corroborated
the importance of the γ-amino butyric acid turn in improving
sequence selectivity.16 Therefore, a binding rule was proposed
that stated that antiparallel pairing of I opposite P (I/P) recog-
nizes a G­C base pair, whereas a P/P pair recognizes A­T or
T­A base pairs (Figure 1).17 Hairpin pyrrole-imidazole poly-
amides (PIPs) possess binding constants and sequence speciﬁc-
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ity that are similar to those of natural transcription factors and
permeate live cells to localize in the nucleus in the presence or
absence of any transfection agent.
2.1 Design of Sequence-Speciﬁc DNA-Binding PIP Fluo-
rescence Conjugates. In recent years, DNA-recognition
elements, such as PIPs, have been complemented with ﬂuo-
rescent properties. As PIP conjugates share similarity with the
DBD of natural transcription factors, they may act as intrinsic
probes to monitor the cellular and nuclear uptake of bioactive
molecules. DNA-binding studies using PIP­ﬂuorophore con-
jugates suggested their remarkable ability to induce ﬂuo-
rescence while maintaining a high degree of speciﬁcity and
aﬃnity after binding to their cognate DNA sequences.18a Inter-
estingly, the nuclear localization of such molecules depends on
a number of restrictions, such as the molecular size, pyrrole/
imidazole content, and the choice of an appropriate dye.18b
Several PIP­ﬂuorophore conjugates display diverse photo-
chemical properties, novel heterocycles, distinct uptake prop-
erties, bioactivity, and eﬃcacy as anticancer compounds.19 The
excimer emission of hairpin PIP dramatically changes after
the substitution of a pyrenylbutyl group. The emissions of
the PIP­ﬂuorophore conjugate excimer increase linearly with
the increasing number of CAG repeats and the concentration
of oligodeoxy nucleotides (ODNs) containing CAG repeats,
which indicates the possibility of quantifying CAG repeat-
containing DNA sequences.20a The evaluation of steady-state
ﬂuorescence spectra of the PIP bis-pyrenyl conjugates with
rigid linkers suggested that the pyrene-functionalized PIP
conjugate, which contains propynyl linkers, shows a clear
increase in excimer emission that is dependent on the number
of CAG repeats in the target dsDNA; moreover, the emis-
sion intensity was considerably retained (Figure 2a).20b Sim-
ilarly, perylene­PIP conjugates were designed and synthe-
sized using Fmoc solid-phase synthesis and a subsequent
Sonogashira coupling reaction. Energy transfer from the
pyrrole moiety to the perylene suggested their possible role
as a molecular light switch (Figure 2b).21 Human telomere
ODNs (5¤­(GGGTTA)4GGG­3¤/3¤­(CCCAAT)4CCC­5¤) were
detected by the combination of PIP conjugates termed 10 and
11 (Figure 2c). Excitation of conjugates 10 and 11 at 313 nm
with telomere ODNs gave intense emission at 462 and 494
nm, suggesting their utility as sequence-speciﬁc ﬂuorescence
probes, because eﬃcient heterodimer formation of a DNA-
binding complex between the PIP­perylene conjugate and the
telomere sequence was observed.22 PIPs controlled the loca-
tion and spatial arrangement of the ﬂuorescent dyes within a
DNA duplex at the base pair level and solved the loss of energy
transfer that occurred because of ineﬃcient self-assembly of
the appropriate communicating components within DNA du-
plexes.9 The design, synthesis, and evaluation of a new type of
Figure 1. Illustration of pyrrole-imidazole polyamides development as DNA-binding domain from the antibiotics that were derived
from bacteria Streptomyces sp.
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hairpin PIP conjugate23 suggested the critical role of the γ-turn
position and β-alanine linker in improving sequence speciﬁcity
(Figure 2d).
The eﬃcacy of the PIP-targeting promoter of the human
transforming growth factor-β1 was monitored after conjuga-
tion with ﬂuorescein isothiocyanate (Figure 3a). The biological
evaluation showed that ﬂuorescein isothiocyanate­PIP conju-
gates localize to the nuclei of human vascular smooth muscle
cells after 2­48 h of incubation (Figure 3b).24a To visualize
telomeres speciﬁcally, a new synthetic route was devised to
create a tandem hairpin PIP in which the tetraamide unit, which
is synthesized in the solution phase, was introduced into Fmoc
solid-phase peptide synthesis. The synthesized tandem PIPs
were successfully targeted to human and mouse telomeres
under mild conditions and allowed easier labeling of telomeres
in cells, while maintaining the telomere structure. Visualization
studies using the tandem PIP­ﬂuorophore conjugates showed
that the telomere length at a single telomere level is related
to the abundance of the TRF1 protein, a shelterin complex
component in telomeres.24b Characterization and microheter-
ogeneity studies further veriﬁed the telomere staining.24c
To improve their selectivity to telomeres by targeting longer
sequences, we designed and synthesized a ﬂuorescent tan-
dem trimer PIP probe that comprised three hairpins and two
connecting regions (hinges). The new motif, TT59, had the
ability to discriminate mismatches and recognize 18 bp dsDNA
in human telomeric repeats (TTAGGG)n.24d The TAMRA-
conjugated tandem trimer PIP probe highlighted the telomere
foci clearly with lower-intensity background signals, indicating
its higher selectivity to telomeres (Figures 3c and 3d). This new
motif may be useful for highlighting speciﬁc regions clearly in
human cells. The construction of cyanine Cy3- or Cy5-hairpin
PIP conjugates and the evaluation of their binding to DNA in
the nucleosome revealed the presence of a distinct binding eﬃ-
cacy, suggesting the possibility of characterizing the dynamic
interactions within protein­DNA complexes (Figure 3e).24e
2.2 Gene Regulation by PIPs Mimicking Transcription
Factor DBDs. PIPs targeted to a speciﬁc gene-coding region
are most eﬀective when the target sequence is unique. How-
ever, attempts to suppress gene expression using PIPs that
target gene regulatory sequences were not straightforward
because of the limitations of ﬂanking sequence recognition and
inhibition by nonspeciﬁc transcription factors. Targeted tran-
scriptional inhibition by the simple binding of PIPs to spe-
ciﬁc sequences may regulate the expression of speciﬁc genes.
Targeting PIPs triggered the speciﬁc regulation of the expres-
sion of therapeutically important aurora kinases (AURKA and
AURKB), TGF-β1, human lectin-like oxidized low-density
lipoprotein, and HER2 and EBNA1.25 Thus, the designed PIPs
successfully modulated the expression of distinct therapeuti-
cally important genes in diﬀerent cell types (Figure 4a). The
human ectopic viral integration site 1 (EVI1) is an oncogenic
transcription factor that plays an essential role in diﬀerent
cancers. We have designed a PIP to target speciﬁc base pairs
of the REL/ELK1 binding site in the EVI1 minimal promoter.
A whole-transcriptome analysis showed that the designed PIP
signiﬁcantly inhibited EVI1 in MDA-MB-231 cells, as well as
breast cancer cell migration.26
Figure 2. Design of DNA-based ﬂuorophore conjugates. Hairpin pyrrole-imidazole polyamides (PIPs) conjugated with a) pyrene20b
and b) perylene.21 c) Structure of perylene­PIP ﬂuorophore conjugates (10 and 11) targeting telomere ODNs (5¤­(GGGTTA)4GGG­
3¤/3¤­(CCCAAT)4CCC­5¤).22 d) Altered PIP­ﬂuorophore conjugate with improved sequence speciﬁcity.23
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To explore the RNA-binding properties of PIPs targeting
TGF-β1 and the inﬂuenza A virus (PA polyamide), we designed
targeting dsRNAs and analyzed their RNA-binding prop-
erties. A Biacore assay showed the fast binding of the TGF-β1
polyamide and not the mismatch to the dsRNA. Targeting PIPs
bound to RNA with a 2 log lower binding aﬃnity compared
with its DNA-binding aﬃnity.27 Our studies showed that
PIPs can bind methylated 5¤­CpG­3¤ sequences.28 Pharmacoki-
netic modeling studies using simultaneous urinary and biliary
excretion data predicted plasma PIP concentration in rats.29a
In addition, the pharmacokinetics of PIPs after intravenous
administration in rat was reported.29b PIP concentration was
determined in rat plasma using liquid chromatography­tandem
mass spectrometry.29c Matrix metalloprotein 9 (MMP-9) is a
therapeutically important type IV collagenase that contributes
to tumor invasion and metastasis. A PIP targeting the acti-
vator protein-1 (AP-1)-binding site of the MMP-9 promoter
(Figure 4b) signiﬁcantly inhibited MMP-9 mRNA expression,
protein levels, and enzymatic activity, as well as migration and
invasion, in human breast adenocarcinoma cells (MDA-MB-
231) (Figure 4c). A mouse model of liver metastasis showed
decrease in liver metastasis (Figure 4d).30 The interference of
PIPs with transcriptional factors also had a positive induction
eﬀect, which suggests that PIPs inhibit both basal and activated
transcription.
2.3 Alkylating PIP Conjugates as Genetic OFF Switches.
The incorporation of a duocarmycin A (Du) moiety into the
PIP structure improves its alkylation eﬃciency. The addition of
distamycin A to the PIP also drastically increases DNA alkyl-
ation, primarily at the G residues of GC-rich sequences.31 In
Figure 3. Bioactive PIP­ﬂuorophore conjugates as smart ﬂuorescent probes. a) Structure of PIP­ﬂuorescein isothiocyanate
conjugates targeting the promoter of the human transforming growth factor-β1. b) PIP­ﬂuorescein isothiocyanate conjugates in the
nuclei of human vascular smooth muscle cells after 2 h. (Figures reproduced from Lai et al.24a). Tandem PIP­TAMRA conjugates
c) TH59 and d) TT59 targeting human telomeric repeats (Figures reproduced from Kawamoto et al.24b,24d). e) Schematic
representation of the designed cyanine Cy3- or Cy5-hairpin PIP conjugates that facilitated the evaluation of dynamic interactions
within protein­DNA complexes.24e
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our laboratory, we engineered PIPs to improve their sequence-
speciﬁc eﬃcacy and their recognition sequences by introducing
vinyl linkers, L-moieties, and indole linkers.32a The require-
ment of β-alanine components in PIP conjugates with seven-
base-pair recognition was shown.32b To extend the length of
the target DNA sequence of the hairpin PIP, we designed and
synthesized Y-shaped and tandem hairpin PIPs possessing 1-
(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole (se-
co-CBI) as DNA-alkylating moieties.32c A comparative analy-
sis of DNA alkylation showed that PIP-seco-CBI conjugates
were distinctly active in cells compared with PIP-chlorambucil
conjugates.32d A long-chain hairpin PIP­chlorambucil con-
jugate with 11 bp recognition targeting CAG/CTG repeat
sequences (which are associated with a variety of hereditary
diseases) was readily synthesized via the introduction of an
amino group into a GABA (γ-turn). In vitro transcription
assays revealed that speciﬁc alkylation inhibited the progres-
sion of RNA polymerase at the alkylating sites.32e
Alkylating PIPs have been developed as anticancer agents.33a
The cooperative alkylation of human telomere repeats by
designed heterotrimeric PIP-seco-CBI and chlorambucil con-
jugates with 11 bp recognition was shown (Figure 5a).33b,33c
The tandem hairpin motif of PIP-indole-seco-CBI conjugates
speciﬁcally alkylated human telomere repeated sequences
(Figure 5b).33d The design of three types of tandem hairpin
PIP TH59 molecules and the evaluation of their binding eﬃ-
cacy revealed the presence of a small molecule with better
aﬃnity to TTAGG sequences in telomere-containing regions.33e
One of the PIP-seco-CBI conjugates showed strong DNA-
alkylating activity and good sequence speciﬁcity regarding the
targeted histone H4 gene fragment; it also induced apoptosis
eﬃciently in K562 cells. A genome-wide analysis further sub-
stantiated their bioactivity, as several histone H4 genes were
downregulated in the presence of the PIP-seco-CBI conju-
gate (Figure 5c).34a The biological evaluation of two alkylat-
ing PIP conjugates with 7 bp recognition ability demonstrated
their potent cytotoxicity against A549 cells and their tumor-
suppressing eﬀect on nude mice with transplantation of DU145
cells (Figure 5d).34b
Mutation of the KRAS gene frequently occurs in diﬀerent
types of cancer where the point mutation usually occurs at
codons 12 and 13. The design, synthesis, and characterization
of diﬀerent types of PIP-seco-CBI conjugates led to the iden-
tiﬁcation of a candidate with high reactivity toward the KRAS
codon 13 mutation site, with alkylation occurring at the A of
the 5¤­ACGTCACCA­3¤ sequence.35a Similarly, a PIP-seco-
CBI conjugate that selectively recognized oncogenic codon 12
KRAS mutations, termed KR12, was synthesized. KR12 speci-
ﬁcally alkylated adenine N3 at the target sequence, thus caus-
ing strand cleavage and growth suppression in human colon
cancer cells carrying G12D or G12V mutations, which in turn
induced senescence and apoptosis. Studies of xenograft models
showed that KR12 infusions induced signiﬁcant tumor-growth
suppression with low host toxicity only in KRAS-mutated, and
not wild-type, tumors. This approach could potentially be
extended to target diﬀerent mutant driver oncogenes.35b A
computer-minimized model and Bind-n-Seq analysis corrobo-
rated that KR12 targets the G12D and G12V mutation sequence
with much higher aﬃnity than that observed for the wild-type
sequence (Figure 5e).35c
Figure 4. Gene regulation using DNA-based PIPs. a) Structure of designed PIPs that target genes in diﬀerent cell types. b) Structure
of match and mismatch PIPs targeting matrix metalloproteinase 9 (MMP-9), a therapeutically important type IV collagenase that
contributes to tumor invasion and metastasis. c) Distinct bioactivity of match MMP-9­PIP. d) Representative mouse model studies
showing the remarkable ability of MMP-9­PIP to inhibit tumor growth compared with the control (Figures reproduced from Wang
et al.30).
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2.4 Improvement of the Chemical Architecture of PIPs.
A surface plasmon resonance assay of ﬁve hairpin PIPs with a
diﬀerent number of imidazole rings showed that the association
rate of PIPs with their target DNA decreased with the increase
in the planarity of PIPs caused by imidazole.36a The evalua-
tion of a single pyrrole replacement with β-alanine in a PIP
targeting 5¤­GCGC­3¤ revealed a distinct DNA-binding aﬃnity
and increased sequence selectivity.36b Substitution of PIPs with
a chiral β-hydroxyl-γ-aminobutyric acid/β-alanine pair eﬀec-
tively discriminated between T/A and A/T base pairs.36c Three
alkylating tandem PIPs that recognize a 10 bp DNA sequence
with diﬀerent linkers were evaluated using high-resolution
denaturing gel electrophoresis. The tandem PIP that contained a
β-alanine linker displayed the most selective sequence-speciﬁc
alkylation toward the target 10 bp DNA sequence.36d These
studies provide knowledge that is fundamental to the improve-
ment of PIP design, as small alterations in the chemical archi-
tecture of PIPs may have a notable eﬀect on their binding
eﬃcacy. A PIP-seco-CBI conjugate that was protected by a
photocleavable group was selectively activated by UV irradi-
ation both in vitro and in vivo, suggesting the possibility of
developing novel chemical- or enzyme-activated anticancer
agents.37a The modiﬁcation of PIP conjugates using methoxy-
polyethylene glycol 750 (PEG-750) improved their aqueous
solubility moderately (Figure 6a).37b A new synthetic route
to introduce a vinylpyrrole unit into the C terminus of a PIP
synthesized via (ﬂuorenylmethoxy)carbonyl solid-phase pep-
tide synthesis and subsequent liquid-phase coupling with seco-
CBI yielded a PIP-seco-CBI conjugate with a vinyl linker that
recognized a 7 bp DNA sequence (Figure 6b).37c The conjuga-
tion of a pseudocomplementary peptide nucleic acid to a hair-
pin PIP selectively targeted the speciﬁc DNA sequence 5¤­
Figure 5. Development of DNA-based genetic OFF switches. a) Chemical structure of a tandem alkylating PIP.33b,33c b) Tandem
hairpin motif of a PIP-indole-seco-CBI conjugate for speciﬁc alkylation of human telomere repeated sequences (Reproduced from
Yamamoto et al.33d). c) A PIP-seco-CBI conjugate with strong DNA-alkylation activity and good sequence speciﬁcity regarding the
targeted histone H4 gene fragment induces apoptosis eﬃciently in K562 cells (Reproduced from Minoshima et al.34a). d) Schematic
illustration of two alkylating PIP conjugates with 7 bp recognition ability demonstrating their potent cytotoxicity against A549 cells
and tumor-suppressing eﬀect on nude mice with transplantation of DU145 cells (Reproduced from Kashiwazaki et al.34b).
e) Structure of KR12 (in which the CBI unit was replaced with Dp and PEG12­biotin was conjugated to the γ-turn): target KRAS-
binding sequence and primary binding motif, as identiﬁed using Bind-n-Seq and next-generation sequencing. (Figures reproduced
from Taylor et al.35c).
Bull. Chem. Soc. Jpn. 2016, 89, 843–868 | doi:10.1246/bcsj.20160062 © 2016 The Chemical Society of Japan | 849
AGTCCT­3¤ and facilitated the sequence-speciﬁc scission of
long dsDNAs.37d A novel method that used cysteine and a
chloroacetyl residue completed the cyclization reaction within
1 h and generated cyclic PIPs that recognized 7 bp DNA se-
quences with a high conversion eﬃciency. Interestingly, cyclic
PIPs containing two β-alanine molecules had higher aﬃnity
and speciﬁcity than did the corresponding hairpin PIPs, which
suggests the possibility of using cyclic PIPs as next-generation
DNA-binding agents (Figure 6c).38a By extending this molecu-
lar design, an eﬃcient cyclization reaction between a cysteine
and a chloroacetyl residue was used for dimerization in the syn-
thesis of a large dimeric PIP that recognizes a 14 bp region in
duplex DNA.38b A pseudocomplementary peptide nucleic acid
(pcPNA) is known to eﬀectively invade dsDNA and recognize
complementary A/T-rich sequences. Despite the versatile use of
pcPNA in recognizing physiologically important DNA struc-
tures like G-quadruplex and telomeric DNA, their invasion
eﬃcacy was poor under physiological ionic strength conditions.
We conjugated pcPNA (decamer) to a designed PIP (Figure 6d)
and evaluated their eﬃcacy. Since the binding occurred even
under high salt conditions, this design overcame the technical
diﬃculties associated with the employment of PNA-PIP con-
jugates in the presence of ion concentrations that is present
under physiological conditions. Our chemical strategy could be
successfully applied to sequence-speciﬁc DNA scission for a
longer target sequence.
2.5 Design of SAHA­PIP Conjugates as Speciﬁc Genetic
ON Switches. In the natural cellular environment, gene
expression is orchestrated at various distinctive levels by epige-
netic enzymes including histone deacetylases (HDACs) and
histone acetyltransferases (HATs) that govern histone acetyla-
tion and DNA accessibility to transcription factors. Disease
triggering epigenetic alteration is intrinsically ﬂexible and
can be reversed via pharmacological intervention. The inhibi-
tion of HDACs by small molecules, such as suberoylanilide
hydroxamic acid (SAHA), has been harnessed to modulate gene
expression. However, they operate in a sequence-independent
manner.7 In our steadfast progress to develop functional bio-
materials that mimic natural transcription factors, we developed
a novel class of compounds termed SAHA­PIPs that contained
sequence-speciﬁc PIPs and SAHA (Figure 7a). Our designed
SAHA­PIPs that targeted the promoter region of the p16 tumor
suppressor gene, but not its mismatch, selectively triggered
histone H3 Lys9 acetylation and induced signiﬁcant morpho-
logical changes in HeLa cells.39 Consequently, we designed 16
types of SAHA­PIPs (A to P) (Figure 7b) that were expected to
yield distinct gene activation by speciﬁcally targeting a 6 bp
sequence based on the binding rule of PIPs. As histone modiﬁ-
cation established and maintained pluripotency in somatic cells,
these SAHA­PIPs were screened for their eﬀect on the genes
associated with the generation of induced pluripotent stem cell
(iPSC) in mouse embryonic ﬁbroblasts (MEFs). Interestingly,
D, E, J, and O distinctively induced the expression of c-Myc,
Nanog, Sox2, and Klf4. SAHA­PIP-mediated gene induction
occurred by establishing transcriptionally permissive chroma-
tin, including Lys9 and Lys14 acetylation and Lys4 trimethyl-
ation of histone H3.40a However, the induction eﬃciency was
very low (5-fold). To improve bioeﬃcacy, a second library of
SAHA­PIPs (Q to ¯) with improved recognition of GC-rich
sequences was synthesized. Screening studies identiﬁed a potent
SAHA­PIP, designated as δ, that was capable of inducing OCT-
3/4 and Nanog by about 30-fold in just 24 h and at nanomolar
concentrations (Figure 7c). A microarray analysis revealed that
δ switched ON multiple pluripotency genes by shifting the tran-
scriptional network from the ﬁbroblast state to the pluripotent
state.40b Interestingly, δ rapidly overcame the mesenchymal­
epithelial transition (MET) stage, which is an important rate-
limiting step of the dediﬀerentiation of the somatic genome.
2.6 Genome-Wide Gene Eﬀect of Genetic ON Switches
in Human Cells. Encouraged by the bioeﬃcacy observed
in MEFs, microarray studies were carried out to evaluate the
eﬀect of 32 SAHA­PIPs (A to ¯) on genome-wide gene
Figure 6. Chemical structure of modiﬁed PIPs and their conjugates. a) PEGylated PIP with improved aqueous solubility.37b b) PIP
conjugates with a vinyl linker.37c c) Cyclic PIP with improved sequence recognition.38a d) Peptide nucleic acid-conjugated PIP for
site-speciﬁc scission.37d
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expression in human dermal ﬁbroblasts (HDFs) (Figure 7d).
Based on extensive analyses that used independent lines of
evidence, we revealed the remarkable ability of unique SAHA­
PIPs to trigger the transcriptional activation of exclusive clus-
ters of developmental genes and to cause similar gene repres-
sion. Furthermore, these targeted transcriptional activators also
activated a diﬀerent set of noncoding RNAs and suppressed a
similar set of noncoding RNAs. QRT­PCR studies validated
the pattern observed in microarray analyses, that SAHA­PIPs
could activate therapeutically important genes like KSR2, the
obesity gene, and SEMA6A, the retinal ON circuit factor. Our
proof-of-concept study suggests the possibility of modulating
the transcription of therapeutically important genes and non-
coding RNAs in a precise manner.41a A functional analysis
revealed the SAHA­PIP termed K as the ﬁrst-ever small mole-
cule that was capable of inducing the transcriptional activa-
tion of germ cell genes in a human somatic cell.41b qRT­PCR
studies showed that K remarkably induced MOV10L1, a germ-
cell-speciﬁc putative RNA helicase that functions upstream of
PIWI pathway factors to maintain postmeiotic genome integ-
rity. This result is remarkable because the meiotic process is
speciﬁc to germ cells and does not occur in somatic cells.
Figure 7. Synthetic DNA-based smart biomaterials with epigenetic activity. a) An innovative small molecule called SAHA­PIP
capable of accessing both the genetic and epigenetic environments encompassing pyrrole-imidazole polyamides (PIPs) with the
chromatin-modifying histone deacetylase inhibitor SAHA. b) Library of SAHA­PIP represented as books (A to P in the top shelf
and Q to ¯ in the lower shelf ). c) A biological evaluation performed using mouse ﬁbroblasts showed that SAHA­PIPs D, E, J, and
O distinctively activated c-Myc, Nanog, Sox2, and Klf4 via site-speciﬁc chromatin remodeling.40a Screening of a second library, Q
to ¯, identiﬁed the SAHA­PIP, δ, which rapidly induced OCT-3/4 to trigger the core pluripotency gene network.40b d) A genome-
wide gene analysis of SAHA­PIP-treated human ﬁbroblasts revealed that distinct SAHA­PIPs, such as K,41b I,41c and X,41d
diﬀerentially activated therapeutically important retinal, stem cell, and germ cell genetic networks.
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Interestingly, SAHA­PIP I, which contains a similar number
of pyrrole and imidazole components as K but recognizes dis-
tinct DNA sequences, displayed a diﬀerent bioactivity, trig-
gered genome-wide epigenetic reprogramming, and turned ON
the typically conserved OCT-3/4 pathway genes. Moreover,
SAHA­PIP I was identiﬁed as the ﬁrst-ever small molecule that
was capable of inducing the miR-302 family, suggesting the
possibility of developing SAHA­PIPs as tools to activate dis-
tinctively cell-fate-regulating microRNAs.41c A ChIP-seq anal-
ysis and an SPR assay conﬁrmed that SAHA­PIP I, but not K,
induced hyperacetylation in the transcribed regions ofOCT-3/4.
Long-term incubation studies generated alkaline-phosphatase-
positive cells with an induction eﬃciency of 0.06 « 0.03% over
21 days, which suggests partial reprogramming.
Retinal tissue is part of the central nervous system and
is susceptible to a wide range of disorders, such as retinitis
pigmentosa (RP). A defect in the CERK gene, which regulates
apoptosis in the retina, may result in the progression of RP. Our
screening studies successfully identiﬁed a SAHA­PIP, X, that
induced the transcriptional activation of CERKL and an array
of potential retinal-cell-speciﬁc therapeutic genes (PAX6, RS1,
USH2A, CRYBB3, and STRA6) that are associated with resist-
Figure 8. The alteration of smart biomaterials causes distinctive bioactivity. a) The second-generation epigenetic switch δ2
containing isophthalic acid (IPA) at the C terminus of a PIP signiﬁcantly boosted its bioeﬃcacy compared with the unmodiﬁed
δ2;42c alteration of the SAHA of SAHA­PIP generated Jδ, which contained speciﬁcity to HDAC8 and was active against skull
morphogenesis genes, such as Otx2 and Lhx1. b) The substitution of SAHA in SAHA­PIP-I or SAHA-I with the HAT activator
CTB generated CTB­PIP-I or CTB-I, which remarkably activated an identical gene network governed by OCT-4 in human
ﬁbroblasts (Reproduced from Han et al.44a).
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ance toward ocular disorders.41d A ChIP-seq analysis revealed
that the highly signiﬁcantly enriched motif closely resembles
the potential binding site of X (5¤­WCGGWW­3¤).
2.7 Chemical Modiﬁcation Aimed at Boosting the
Bioeﬃcacy of Genetic ON Switches. Modiﬁcations of the
chemical architecture of genetic ON switches, such as SAHA­
PIPs, are expected to improve their versatility and bioeﬃcacy.
As a ﬁrst step in the evaluation of the eﬀect of alterations in
the PIP architecture of SAHA­PIPs, we synthesized diﬀerent
conjugates of SAHA­PIP E by varying the number of β-alanine
linkers and the placement of the SAHA moiety. The biological
evaluation of E conjugates that were capable of inducing OCT-
3/4 and Nanog expression showed that their expression levels
were moderately increased in the presence of three β-alanine
linkers in SAHA­PIP.42a We then altered the structure of SAHA
in SAHA­PIP δ to generate a new type of smallmolecule called
JAHA­PIP δ or Jδ, which lacked the surface-recognition
domain of SAHA. An enzymatic activity assay and biological
studies demonstrated that this modiﬁcation could alter the
HDAC speciﬁcity of δ, because Jδ displayed a signiﬁcantly
higher activity against HDAC8 compared with HDAC1. Inter-
estingly, the HDAC8-speciﬁc Jδ also rapidly activated skull
morphogenesis associated HDAC8 regulated Otx2 and Lhx1,
thus opening exciting opportunities in regenerative medicine.42b
To boost the bioeﬃcacy of δ, we incorporated an isophthalic
acid (IPA) at the C terminus of a PIP, to improve its aqueous
solubility and prevent aggregation. A biological evaluation
showed that this chemical modiﬁcation signiﬁcantly (P < 0.05)
boosted its bioeﬃcacy against pluripotency genes compared
with the unmodiﬁed δ.42c A next-generation sequencing (Bind-
n-seq) analysis determined the sequence-speciﬁcity bias of
SAHA­PIPs and led to the design of second-generation (ββ­
PIPs) with enhanced binding speciﬁcity.43 ChIP­PCR studies
further showed that the model oligonucleotide duplex could be
extrapolated to the corresponding sequence within chromatin.
These results validate the scope of tailoring SAHA­PIPs and
improving their eﬃcacy (Figure 8a).
Transcriptionally permissive marks are acquired more reli-
ably by activating the epigenetic writers, such as HATs, than by
blocking the erasers, such as HDACs. Considering the essen-
tial role of HATs in gene regulation, we altered SAHA­PIP I
or SAHA-I by substituting HDAC-inhibiting SAHA with a
known HAT activator [N-(4-chloro-3-triﬂuoromethyl-phenyl)-
2-ethoxy-benzamide] or CTB, to generate CTB­PIP I or CTB-
I. The comparison of the bioeﬃcacies of SAHA-I and CTB-I
showed that CTB-I remarkably boosted the bioeﬃcacy of CTB
and activated a cluster of genes that was similar to that ob-
served for SAHA-I in HDFs. An HDAC activity assay per-
formed in cells treated with individual eﬀectors showed that
CTB did not possess HDAC inhibitory activity. A ChIP-seq
analysis revealed that the peaks located around the putative
promoter region were identical in CTB-I- and SAHA-I-treated
HDFs. Our study suggests that distinct functional small mole-
cules can be transformed to have identical bioactivity when
conjugated with a targeting DNA-binding domain, such as PIP
I (Figure 8b) This proof-of-concept study veriﬁed the switch-
able roles of HDACs and HATs in gene regulation and pre-
sented a molecular basis for the development of versatile
bioactive ligands.44a
By conjugating CTB with a nanoparticle-based artiﬁcial
transcription factor with a predesigned PIP, we successfully
expanded the concept of the integration of epigenetic modu-
lators. This platform, which was termed NanoScript, was
designed to target and activate the endogenous expression of
Sox9, a master regulator of chondrogenic diﬀerentiation.44b
Fluorescence imaging and qPCR studies showed that Nano-
Script-Sox9, when incubated with adipose-derived mesenchy-
mal stem cells, eﬀectively activated the expression of chon-
drogenic markers.
3. Structural and Molecular Recognition Properties
of Nucleic Acids: Mechanistic Investigation
for Advancing Small Molecule Interactions
Conformational changes in DNA may inﬂuence the regu-
lation of its biological functions, such as gene expression, in
living systems. The left-handed Z-DNA represents a higher-
energy form of the double helix. Sequences that favor Z-DNA
formation are often located in the promoter region; hence, this
type plays a critical role in facilitating transcriptional initia-
tion and activation. The torsional strain derived from negative
supercoiling, such as that generated by an actively transcribing
polymerase or by a nucleosome-remodeling event, is known
to stabilize Z-DNA. We demonstrated that the human SWI/
SNF-complex-mediated chromatin remodeling induces Z-DNA
formation on a nucleosome.45
3.1 G-Quadruplex Formation: Mechanism and Ligand
Interaction. The G-quadruplex formation is a signiﬁcant
conformational change that is associated with diverse structural
variations and functions. For the development of eﬀective anti-
cancer and anti-aging drugs, it is important to understand the
functional relevance of the G-quadruplex structure in bio-
logically signiﬁcant regions, such as the single-stranded telo-
mere terminus. In the telomere region, the association between
the T-loop structure, which is suggested to protect chromosome
ends, and the G-quadruplex structure is poorly understood. We
proposed a model “lariat” structure in the human telomere
region by designing a new, distant intrastrand quadruplex struc-
ture, and characterized its properties using CD spectroscopy,
FRET, and native PAGE analysis (Figure 9a).46a The results of
these experiments suggested that not only strand encroachment
but also G-quadruplex formation stabilize the T-loop structure.
The great number of tandem repeats in the human telomere
may yield higher-order G-quadruplex structures; however, their
orientation at the end of these structures is poorly under-
stood. Our studies using end-extended and BrG-substituted
oligonucleotides showed that the ends of stable G-quadruplex
structures pointed in opposite directions and indicated that the
human telomere DNA is likely to form rod-like structures
(Figure 9b).46b
To understand the folding pathways that lead to the for-
mation of human telomeric type-1 and type-2 G-quadruplex
structures, we carried out studies using intermediate hairpin
and triplex structures. Our calculation studies suggested that a
triplex intermediate, as a G-triplet structure, appeared to be
more stable than the hairpin conformation and was equally
stable to the G-tetrad structure.47a The simulation studies sug-
gested the importance of K+ association in facilitating the
overall folding via a decrease in electrostatic repulsion. Further
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studies revealed the increase in the number of anti and not syn
conformations with the folding and the preferential K+ binding
to a hairpin near the second lateral TTA loop. Moreover, the
stacking of G-tetrads with the same conformation appeared to
be more stable than the mixed equivalent. A subsequent study
aimed at investigating intramolecular folding in three-tandem
guanine repeats of the human telomeric DNA using optical
tweezers showed the presence of a structure that was consist-
ent with triplex conformation. Similarly, a DNA sequence with
four-tandem guanine repeats showed that a similar species
coexisted with a G-quadruplex (Figure 9c).47b
We devised an integrated approach encompassing the force-
jump method and a statistical population deconvolution at the
subnanometer resolution to study human telomeric sequences
containing four to eight TTAGGG repeats. This fast transition
kinetics study conﬁrmed G-triplexes as the intermediates to G-
quadruplexes and revealed that the long-loop G-quadruplexes
were misfolded population minorities, whereas G-quadruplexes
with the shortest TTA loops were the dominant species.47c
Using the laser tweezer method, we obtained important insights
into the kinetic, thermodynamic, and mechanical properties of
small molecules, such as pyridostatin, that bind to telomeric
DNA G-quadruplex structures.48a The development of small
molecules that are capable of binding G-quadruplex structures
is often hindered by submolecular elements, such as loops and
tetraguanine planes. However, it is diﬃcult to assess G-
quadruplex stability and the roles of speciﬁc residues inside
cells, and traditional studies usually involve mutations. We
used click chemistry and attached pulling hands via two
modiﬁed guanines in each of the three G-quartets in human
telomeric G-quadruplex structures to quantify loop interaction
and G-quadruplex stability at the submolecular level.48b
3.2 Exploiting the Photoreactivity of Nucleic Acids as a
Probe. Understanding the migration of negative or positive
charges (excess of electrons or electron holes) in DNA may
unravel the DNA repair mechanism and be harnessed for the
development of DNA-based smart nanodevices. Photoproducts
that mirror the nucleic acid local structure are useful indica-
Figure 9. G-quadruplex folding pathways. a) Lariat structure encompassing a G-quadruplex and a T-loop structure (Image from Xu
et al.46a). b) Schematic representation of the orientation of the ends of a G-quadruplex structure, as assessed using end-extended
oligonucleotides (Image from Sannohe et al.46b). c) Folding pathways of human telomeric type-1 and type-2 G-quadruplex
structures (Image from Mashimo et al.47a).
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tors of conformational changes at sequence resolution during
irradiation.49a To understand DNA conformational changes and
reaction mechanisms that occur in a short period within a liv-
ing cell, we employed photosensitive 5-halouracil-substituted
DNA, in which thymine (T) was substituted with 5-halouracil
moieties, such as bromouracil (BrU) or iodouracil (IU). The
analysis of the photoreaction of iodouracil in a DNA duplex
indicated that the C­I bond is cleaved via two diﬀerent
pathways, namely “hemolysis” and “heterolysis”, and that the
ratio of these pathways is dependent on the DNA sequence
(Figure 10a).49b The eﬃciency of the photoinduced negative-
charge transfer, termed excess electron transfer (EET), through
DNA was evaluated using BrU and a naphthalene derivative as
the electron donor. Despite the frequent use of BrU in a number
of EET studies, the nature of the products in an EET system
is poorly understood. We directly analyzed the products in an
EET system using HPLC, and demonstrated that the distribu-
tion of products generated by the uracil-5-yl radical is largely
dependent on the distance between the donor and the accep-
tor (Figure 10b).49c A labeling experiment using H(2)(18)O
suggested the involvement of hole migration from the Py(•+)
formed after charge separation in the reaction. Subsequently,
we incorporated a guanosine instead of a deoxyguanosine into
Z-DNA, and found that electron transfer occurred via a diﬀer-
ent mechanism, four-base π-stacks, by modifying the oxidation
potential of the C2¤ radical.49d This study contributed to the
understanding of the unique four-base π-stack-based photo-
reactivity of Z-DNA. The photoreaction of BrU-containing
DNA was used to probe two consecutive G-quadruplexes that
were formed by longer human telomeric DNA. Interestingly, a
notable diﬀerence in the eﬃciency of photoreaction was
observed for eight TTAGGG repeats in K+ and Na+ solutions,
suggesting the presence of diﬀerent loop structures between
two consecutive G-quadruplexes (Figure 10c). A subsequent
molecular simulation generated dimeric models of the consec-
utive structures in K+ and Na+ solutions, to study and compare
the loop regions located between two G-quadruplex units. Our
method developed in the biologically relevant K+ solution
Figure 10. Photoreactivity of 5-halouracil-substituted DNA. a) Photoreaction of iodouracil in a DNA duplex showing the cleavage
of a C­I bond via hemolysis and heterolysis pathways.49b b) A BrU-containing excess electron transfer system suggests that the
distance between the donor and the acceptor aﬀects the proportion of C1¤ and C2¤ oxidation products of DNA (Reproduced from
Tashiro et al.49c). c) Photoreactivity of the linker region to two consecutive G-quadruplexes (Reproduced from Li et al.49e).
d) Structure of pyrene-conjugated PIPs (PPIs).51a e) Schematic representation of the photoreaction-based detection technique that
was used to screen and identify the preferential binding site of PIP (Reproduced from Saha et al.51c).
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potentially detected higher-order G-quadruplex formation in
long human telomeric DNA in cells.49e
To understand RNA conformational changes, we incorpo-
rated BrU into three types of synthetic RNAs and analyzed the
photoproducts using HPLC and MS analyses. In A-form RNA,
the photoirradiation of r(GCABrUGC)2 and r(CGAABrUUGC)/
r(GCAAUUCG) yielded the corresponding 2¤-keto adenosine
product at the 5¤-neighboring nucleotide. In Z-form RNA,
the photoirradiation of r(CGCGBrUGCG)/r(CmGCACmGCG)
yielded the 2¤-keto guanosine product. Conversely, the photo-
irradiation of r(CGCGBrUGCG)/r(CmGCACmGCG) in A-form
RNA yielded almost no products. Taken together, these results
imply that hydrogen (H) abstraction by the photochemically
generated uracil-5-yl radical selectively occurs at the C2¤ posi-
tion and provides a 2¤-keto RNA product.50
The methods available currently to investigate the mecha-
nisms of electron transfer to DNA are intramolecular. To inves-
tigate these mechanisms in an intermolecular manner, we syn-
thesized pyrene-conjugated PIPs (PPIs) (Figure 10d) to achieve
sequence-speciﬁc electron injection into DNA, and detected
electron transfer using BrU as an electron acceptor. We synthe-
sized 12 diﬀerent BrU-containing oligomers and showed that
the electron transfer from PPIs was localized in a range of
8 bp, thus demonstrating that PPIs can be used as a biomaterial
for sequence-speciﬁc electron injection.51a Using slab gel se-
quences and a capillary sequencer, we analyzed two DNA frag-
ments of 298 and 383 bp, respectively, to locate the uracil-5-yl
radical upon 302 nm irradiation. Studies using a hydrogen donor
after tetrahydrofuran and subsequent UDG treatment revealed
that the employed hot-spot sequence 5¤­(G/C)[A]n=1,2BrUBrU­
3¤ and the reverse sequence 5¤­BrUBrU[A]n=1,2(G/C)­3¤ acted
in a similar fashion. This study opens the possibility of attain-
ing information about the interface between nucleic acid and
protein­DNA interactions.51b
A novel technique based on the photochemistry of BrU-
substituted DNAwas developed to detect the binding site of the
gene-switching PIPs (Figure 10e). Using photoinduced elec-
tron injection, we analyzed the binding sites of four pyrene-
conjugated PIPs, 1­4, in two long BrU-substituted DNA frag-
ments of 381 and 298 bp, respectively, and further estimated
their binding aﬃnity, speciﬁcity, and orientation preferences.
High-resolution denaturing gel electrophoresis and PAGE
analysis revealed a unique pattern: 1 and 2 injected electrons
with low sequence speciﬁcity and 3 and 4 injected electrons
with high sequence speciﬁcity.51c Interestingly, this technique
also detected reverse-orientation binding sites, as observed for
2. This platform would be useful in identifying the binding
sites with the highest aﬃnity and in facilitating the design and
development of PIPs.
4. Design of Biomimetic DNA Nanostructures
DNA is a constructive molecule that is capable of achiev-
ing complicated patterns, large scaﬀolds, and the placement of
functional molecules and nanomaterials, because of its self-
assembling feature according to a predesigned program.52 By
harnessing the DNA self-assembly system, our research
focuses on three broad points: (i) programmed assembly and
control of nanostructures with diﬀerent dimensions, and their
functionalization; (ii) visualization of single-molecule inter-
actions and chemical/enzymatic reactions in a mimicked
nanospace; and (iii) construction of molecular nanosystems
and nanodevices with biological applications.
4.1 Monitoring Biomolecular Interactions in Designed
DNA Nanoscaﬀolds. Predesigned two-dimensional (2D)
DNA structures facilitate the artiﬁcial reconstruction of the
complicated patterns observed in the natural cellular environ-
ment to analyze single-molecule interactions and attain mecha-
nistic insights about them. In nature, the DNA methylation
enzyme EcoR1 methyltransferase (M.EcoR1) bends duplex
DNA to ﬂip out the second adenine in the GAATTC sequence,
thus preceding the methyl transfer reaction. To monitor this
essential biomolecular interaction, we designed and prepared a
rectangular 2D DNA scaﬀold termed “DNA frame” (80 © 90
nm) to mimic nanoscale spatial resolution and evaluate the time-
resolved reaction coordination between the enzymes and the
substrate. In the vacant rectangular area (40 © 40 nm) located
inside the DNA frame, we introduced four connections and
hybridized a tense (64mer) and a relaxed (74mer) double-strand
DNA (Figure 11a). Atomic force microscopy (AFM) studies
aimed at monitoring the interaction of M.EcoR1 revealed that
methylation preferentially occurred in the relaxed 74mer du-
plex. Biochemical analyses and RT­PCR studies further cor-
roborated this observation, thus substantiating the critical role of
structural ﬂexibility in the methyl transfer reaction.53a Similarly,
we artiﬁcially constructed a tension-controlled dsDNA substrate
and demonstrated the signiﬁcance of the bending of the duplex
during the glycosylation/AP-lyation reaction of the DNA base-
excision repair enzymes 8-oxoguanine glycosylase and T4
pyrimidine dimer glycosylase.53b To visualize the transcription
process via the molecular movement of RNA polymerase
(RNAP), we attached a template dsDNA (1000 bp) containing
the T7 promoter at two speciﬁc positions on a DNA origami
nanostructure (Figure 11b). High-speed (HS)-AFM studies
showed the DNA binding, sliding, RNA synthesis, dissociation,
and the mechanical behavior of RNAP during the transcrip-
tion process.53c Moreover, we constructed a DNA scaﬀold to
visualize the cleavage and dissociation of dsDNA by a Zn2+-
dependent DNAzyme, and observed the eﬀect of conﬁgura-
tion changes.53d Transcriptional regulation is inﬂuenced by the
combinatorial eﬀect of proteins. For example, the pairing of
SOX2 with PAX6 triggers the transcription machinery toward a
neuronal cell fate. To understand the binding mode of SOX2 to
diﬀerent transcription factors and their capability to swap
partners, we artiﬁcially reconstructed the tensile force in the
DNA frame (Figure 11c). AFM studies revealed that DNA
bending is required for SOX2 binding. Moreover, the SOX2­
PAX6 complex showed increased occupancy on the DNA
element compared with SOX2, which validated the importance
of complex formation in site-speciﬁc DNA binding.53e
Epigenetic enzymes, such as the Tet family proteins, convert
5-methylcytosine (mC) to 5-hydroxymethylcytosine and sub-
sequently to 5-formylcytosine and 5-carboxylcytosine. Using
an HPLC-assisted Tet activity assay, we found that CGmCGCG
was a versatile substrate and demonstrated the preference of
Tet toward single-stranded DNA vs double-stranded DNA.54a
To understand the structural changes that occur in a nucleo-
some during epigenetic modiﬁcations, we reconstituted nucle-
osomes using methylcytosine- or hydroxymethylcytosine-
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Figure 11. Visualization of protein­DNA interactions in DNA nanoscaﬀolds. a) Structure of a DNA nanoframe containing double
strands with diﬀerent tensions, to visualize the interaction of the DNA methylation enzyme EcoR1 methyltransferase (M.EcoR1)
(Reproduced from Endo et al.53a). b) A deﬁned DNA nanostructure that was used to visualize the transcription process via the
molecular movement of RNA polymerase (RNAP) in a template dsDNA (1000 bp) containing the T7 promoter (Reproduced from
Endo et al.53c). c) DNA origami frame used to visualize Sox2­Pax6 complex formation on a regulatory DNA element (Reproduced
from Yamamoto et al.53e). d) A ﬁve-well DNA nanoscaﬀold used to visualize the sequence-speciﬁc single-molecule alkylation
of PIP (Reproduced from Yoshidome et al.55a). e) Visualization system used for studying site-speciﬁc recombination events
(Reproduced from Suzuki et al.56a).
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substituted DNA. AFM studies showed that cytosine methyl-
ation induced a larger eﬀect on the overwrapping of the DNA
around the histone octamer compared with that observed for
cytosine hydroxymethylation. This observation suggests that
diﬀerent DNA modiﬁcations inﬂuence the compaction and
relaxation of the chromatin structure, which in turn regulate
gene expression.54b
Synthetic alkylating PIPs modulate selective gene tran-
scription via the sequence-speciﬁc alkylation of target dsDNAs.
To directly visualize the selective alkylation of the target site
by alkylating PIPs, we designed a new DNA scaﬀold termed
“ﬁve-well DNA frame” that contained ﬁve diﬀerent dsDNA
sequences (Figure 11d). Visualization studies using a doubly
functionalized PIP with seco-CBI and biotin showed the
alkylation of the fully-matched target sequence AGTXCCA/
TGGYACT (X = G) with 88% selectivity; moreover, they
eﬀectively discriminated one-base mismatched (X = A, T, C)
sequences.55a This observation validated the selective alkylat-
ing eﬃcacy of PIP conjugates. Similarly, the site-speciﬁc
positioning of the selective gene that modulates zinc ﬁnger
proteins (ZFPs) was shown on DNA origami structures, thus
substantiating the distinct recognition ability of ZFPs.55b Site-
speciﬁc recombination is a form of genetic recombination that
involves the reciprocal exchange between deﬁned DNA sites.
The actual role of the topological state of the substrate in the
formation of a recombinase­DNA synaptic complex remains
unknown. For this purpose, we reconstructed this event in a
DNA-frame nanoscaﬀold. HS-AFM analyses revealed that the
loxP-containing substrate strands in the antiparallel orientation
recombined only via the formation of synaptic complexes
(Figure 11e). DNA frames tethered with Holliday junction (HJ)
intermediates as a starting substrate in diﬀerent connection pat-
terns suggested that the topological state of the HJ intermedi-
ates dictates the outcome of the resolution.56a
As HJ resolution is a critical step in the completion of homo-
logous recombination, we reconstructed ﬂexible and inﬂexible
junctions and found that only ﬂexible junctions were eﬃciently
resolved into two duplexes upon binding to Bacillus subtilis
RecU HJ resolvase. This study demonstrated the signiﬁcance of
structural malleability and cleavage preferences in this proc-
ess.56b To directly visualize the DNA structural changes that
occur upon photosensitization, we introduced a pair of photo-
responsive oligonucleotides containing azobenzene moieties
into the double-stranded DNA within the DNA frame. AFM
studies clearly demonstrated that the two dsDNAs were dis-
sociated by UV irradiation and hybridized under visible light,
which suggests the establishment of an observation system
for investigating molecular switches at the single-molecule
level.57a RNA molecules underwent structural changes via spe-
ciﬁc hairpin loops to form a complex termed “kissing com-
plex”. To study the interaction between RNA molecules and
molecular switches, we introduced two types of RNA mole-
cules into a DNA origami structure and studied their interaction
with ligands at the single-molecule level. AFM studies demon-
strated the switching function of a designed RNA aptamer
called guanosine triphosphate (GTP) switch that can bind to the
target RNA hairpin in the presence of GTP in the nanospace.57b
4.2 Monitoring DNA Conformational Changes in
Designed DNA Nanoscaﬀolds. The visualization of DNA
conformational changes in a deﬁned nanoscaﬀold may facil-
itate the wider understanding of structural changes and reaction
mechanisms. A deﬁned nanosystem that was constructed to
control the binding of the Zαβ protein to the target sequence
showed that the rotation of the double helix is a critical fac-
tor for protein binding and reactions. We characterized the
properties of Zαβ binding to the analogues of a (CG) repeat
sequence and demonstrated its preferential binding to the Z-
form.58a We mimicked rotary proteins by constructing a DNA-
based molecular machine with rotary function, and visualized
the B­Z conformational transition within a DNA frame. We
switched the motor ON and OFF by introducing conditions
that stabilize B-DNA and by adding a Z-DNA-promoting
high-saline buﬀer, respectively.58b External stimulation with
MgCl2 rotated 70% of the motors, but not the stators/controls
(Figure 12a).
In 2010, we used HS-AFM to report the ﬁrst-ever real-time
observation of a reversible DNA conformational change by
monitoring the G-quadruplex-induced global change of two
duplexes incorporated into a DNA nanoscaﬀold.59a The intro-
duced G-rich strands formed an interstrand (3+1) X-shaped
state via the addition of K+, whereas the removal of K+
disrupted the structure, to create a parallel state (Figure 12b).
We successfully performed a two-step cascading transforma-
tion reaction in a single DNA nanosystem by integrating a
wavelength-dependent photoswitch and a metal ion-dependent
switch (K+).59b Using HS-AFM, we observed a series of dual-
switching logical behaviors that corresponded to conforma-
tional changes (Figure 12c). This system may contribute to the
tracing of signal conversion in DNA computing and to creating
versatile sensing devices. We developed a nanosystem to
demonstrate the formation and dissociation of dsDNAs con-
taining the GQ sequence and the counterpart i-motif sequence
at the single-molecule level (Figure 12d). The topologically
controlled GQ/i-motif dsDNA in the DNA frame was obtained
in high yield via sequential manipulation of DNA strands, the
toehold strand, and the addition and removal of K+. The GQ/
i-motif duplex prepared in this way resolved the dsDNA into
the GQ sequence and the i-motif by the addition of K+ and/or
under an acidic condition in the promoter region. The disso-
ciation of a dsDNA containing the GQ- and the i-motif-forming
sequence was monitored and controlled in the DNA frame.
This system is useful to elucidate the dynamic formation of the
GQ and i-motif involved in the regulation of gene expression in
the promoter region.59c
We incorporated two duplex DNAs inside a DNA origami
frame with G­Gmismatch repeats in the middle of it, to monitor
the topological changes of the strands.60a The addition of KCl
induced DNA synapsis without disturbing the duplex regions
of the participating sequences and resulted in an X-shaped
structure. This arrangement allowed control of strand orienta-
tion and topology and of the stoichiometry of G-quadruplex
formation. Subsequently, we performed a real-time analysis of
the chaperone activity of HIV-1 nucleocapsid proteins (NCps),
which facilitate the remodeling of nucleic acids during G-
quadruplex formation.60b The analysis of the properties of the
proteolytic intermediate NCp15 and the mature NCp7 revealed
that the protein particles primarily existed in monomeric form
and provided stoichiometry data regarding the formation and
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dissociation events. This study may contribute to the design of
anti-HIV drugs based on G-quadruplexes. The G-quadruplex-
binding ligands may be used to target the G-rich sequences that
occur in human chromosome telomeres and in the promoter
region of several proto-oncogenes. We visualized directly the
formation of a G-quadruplex structure using bisquinolinium
pyridine dicarboxamide with a linker containing biotin at one
end.60c
This system facilitated the nanoprecise capture of unprece-
dented solution-state structures of a tetramolecular antiparallel
and of (3+1)-type G-quadruplex intermediates (Figure 12e).61a
The stable intermediates, such as G-hairpins and G-triplexes,
formed with good yield. Moreover, the interplay between these
intermediates, divalent Mg2+ ions, and monovalent K+ ions
was shown. These results substantiated our previous simulation
study of G-quadruplex folding pathways.47a Consequently, we
also captured the solution-state structures of the complexes that
were formed between streptavidin and a G-hairpin/G-triplex
and revealed that the binding of ligands to the intermediates
leads to stepwise folding into a quadruplex structure.61b The
development of this system may provide a broader under-
standing of the interaction between G-quadruplexes and their
targeting drugs.
4.3 Programmed Assembly of Nanostructures with
Diﬀerent Dimensions. The programmed assembly/control
of nanostructures with diﬀerent dimensions is among the ulti-
mate goals of supramolecular chemistry and is a critical method
in bottom-up nanotechnology. Rothemund et al. reported that
DNA origami, a DNA self-assembly system, can be used to
construct fully addressable 2D plates and diﬀerent 2D struc-
tural patterns. The combination of the DNA origami method for
the preparation of 2D DNA scaﬀolds and subsequent folding
via their connection strands allowed us to achieve three-arm (Y-
shaped), four-arm (X-shaped), and six-arm (asterisk-shaped)
structures. Using a template single-stranded DNA (M13mp18),
nine strands were introduced into one side of each arm, to con-
nect to the adjacent arm. Two thymidines (T2) were introduced
to connect a counterpart site on the adjacent arm, for ﬂexibility
during the hybridization of the connection strands. The de-
signed hollow three-dimensional (3D) prism structures com-
Figure 12. Visualization of DNA conformational changes. a) A rotary protein mimicking a DNA-based molecular machine with
rotary function was used to visualize the B­Z conformational transition (Reproduced from Rajendran et al.58b). b) DNA-based
nanosystem used to visualize the reversible G-quadruplex conformational transformation (Reproduced from Sannohe et al.59a).
Schematic illustration of the monitoring of c) dual-switching behaviors corresponding to the state transition in a DNA nanoframe
(Reproduced from Yang et al.59b) and d) the single-molecule manipulation of duplex formation and dissociation at the G-
quadruplex/i-motif site (Reproduced from Endo et al.59c). e) Single-molecule visualization of the solution-state structures of G-
hairpin and G-triplex intermediates (Reproduced from Rajendran et al.61b).
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prised three (eight helices), four (six helices), and six (four
helices) rigid rectangles (24 helices) and were connected by
ﬂexible hinges (Figure 13a).62 We developed a novel method
to design 2D DNA origami rectangles, termed “DNA jigsaw
pieces,” and contained sequence-programmed connectors. For
the selective connection of DNA rectangles, we introduced
shape and sequence complementarity into the concave and
convex connectors via nonselective π-stacking interactions
between the side edges of the DNA jigsaw piece structures. We
assembled three and ﬁve DNA jigsaw pieces with the correct
alignment and uniform orientation into predesigned ordered
nanostructures, to obtain three-, four-, and ﬁve-letter words
(Figure 13b).63a Subsequently, a four-way connector led to the
successful assembly of ﬁve and eight origami monomers and
the formation of a cruciate and a hollow square structure,
respectively (Figure 13c).63b We scaled up the origami struc-
tures to achieve the programmed 2D self-assembly of multiple
DNA origami jigsaw pieces. To accomplish 2D self-assembly
along the helical axis (or horizontal direction) and the heli-
cal side (or vertical direction), we introduced a sequence-
programmed structure (tenon and mortise) and the sequence
complementarity of single-stranded overhangs, respectively.
The design and preparation of nine diﬀerent jigsaw pieces to
attain a 3 © 3 assembly in four diﬀerent ways showed that the
stepwise self-assembly from the three vertical trimer assem-
blies gave the intended 2D construction with a yield of about
35%. The surfaces of the jigsaw pieces decorated with hairpin
DNAs self-assembled into a 2D structure and displayed letters
that formed the word “DNA JIG SAW” at the nanoscale.63c To
achieve control over the 2D crystallization of DNA origami,
we introduced loops on their surface. Studies performed using
diﬀerent orientations revealed that the vertical alignment was
the only appropriate orientation to attain the 2D crystal lattice
on a micrometer scale (Figure 13d).63d
The controlled assembly of the kinetic and thermodynami-
cally stable G-quadruplex DNA structure is diﬃcult because
of the rules of recognition. To overcome this issue, a design
was proposed that combines parallel-stranded duplexes and a
quadruplex core, to assemble and visualize quadruplex-based
1D structures that are capable of accommodating potential
modiﬁers.64a The DNA origami method was used to design and
prepare the size-controlled tubular structures 6-tube, 8-tube,
and 10-tube, which contain 192, 256, and 320 base pairs over
one round, respectively (Figure 13e).64b A detailed analysis of
the tube surface patterns showed that the expected short tubes
and unexpected long tubes had mainly a left-handed helical
Figure 13. Programmed assembly of nanostructures. a) Multiarm DNA structures with connection strands that were folded to produce
hollow prism structures (Image from et al.62). b) Designed 2D DNA origami rectangles with sequence-programmed connectors
formed “DNA jigsaw pieces” (Image from Endo et al.63a). c) A four-way connector with connection sites at all four edges was
assembled to form a cruciate and a hollow square structure (Image from Endo et al.63b). d) Illustration of the 2D crystallization of
DNA origami with diﬀerent loop arrangements (Image from Rajendran et al.63d). e) Helical DNA origami tubular structures with
various sizes and arrangements (Image from Endo et al.64b). f ) Schematic of the preparation of chemically modiﬁed RNA origami
nanostructures Helical DNA origami tubular structures with various sizes and arrangements (Image from Endo et al.64c).
860 | Bull. Chem. Soc. Jpn. 2016, 89, 843–868 | doi:10.1246/bcsj.20160062 © 2016 The Chemical Society of Japan
structure and right-handed structure, respectively. Interestingly,
the population of the left-/right-handed and short/long tubes
changed in accordance with the number of base pairs involved
in one round of the tubes. The variable formation of tubular
structures is suggested to be associated with the helical stress
caused by the stiﬀness of the double helices and the nonnatural
helical pitch in the DNA origami design. Using RNA templates
containing chemically modiﬁed uracils, we constructed RNA-
templated DNA origami structures by annealing with designed
DNA staple strands and folding, to form seven-helix bundled
rectangular structures and six-helix bundled tubular struc-
tures (Figure 13f ).64c We successfully used cationic comb-type
copolymers as locks based on their ability to restrict origami
folding by binding to the phosphate backbone of M13mp18/
staples, together or alone. We used polyvinyl sulphonic acid
as a key to demonstrate the controllable fabrication of DNA
origami structures.64d
We constructed a cuboid structure based on a square prism
structure and characterized the structure using AFM and
dynamic light scattering.64e This study proposes the develop-
ment of functional nanostructures with controllable closing and
opening processes.
4.4 Guided Assembly and Control of Molecular Nano-
systems and Nanodevices. Molecular assembly assisted by
factors such as enzymes and light may guide the design and
control of molecular nanosystems and nanodevices. Using
Figure 14. Guided assembly of nanostructures. a) A DNA transportation system constructed using a mobile DNA nanomachine
along a designed track on the DNA origami surface (Image from Wickham et al.65a). b) A single-molecule mechanochemical
sensing platform with a seven-tile DNA origami nanostructure (Image from Koirala et al.66b). c) Simpliﬁed illustration of the
molecular model of a novel rotatable DNA unit (Image from Tashiro et al.66c). d) Schematic representation of a transcription-
regulation system mediated by the mechanical operation of a DNA nanostructure (Image from Endo et al.66d). e) Dynamic
assembly/disassembly of photoresponsive DNA origami nanostructures visualized on a lipid-bilayer membrane surface (Image
from Suzuki et al.67c). f ) Photoresponsive DNA nanocapsule with an open/close system for the capture and release of
nanomaterials (Image from Takenaka et al.67d). g) A photocontrolled DNA nanomachine on the DNA nanostructure (Image from
Yang et al.67e). h) Lipid-bilayer-assisted 2D self-assembly of DNA origami nanostructures (Image from Suzuki et al.70).
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Watson­Crick base pairing, a molecular transportation system
was constructed in which the track, a motor, and fuel were
all prepared from DNA. The DNA nanomachine system was
loaded at one end of the track and moved autonomously along
the full length of the track that was designed to contain 17
stators on the DNA origami scaﬀold using 16 consecutive steps
(Figure 14a). Visualization studies using AFM suggested that
this stepwise-controlled movement is one directional and time
dependent, which indicates the potential use of this system to
create molecular assembly lines modeled on the ribosome.65a
Similarly, a branched motor track with three branching points
and four ﬁnal destinations was constructed on the DNA
origami scaﬀold. The pathway and destinations of the DNA
motor were controlled in a programmed fashion using the block
strands at both sides of the branching points and the corre-
sponding release strands. The navigation of the DNA to the
ﬁnal destination was observed using AFM and the ﬂuorescence
quenching method.65b
We also developed a novel DNA scaﬀold, called a DNA slit,
for the thiol-guided programmed placement of Au nanoparti-
cles.66a A DNA origami method based on mechanochemical
principles was developed to construct a throughput single-
molecule biosensing platform by incorporating six sensing
probes at diﬀerent locations of a seven-tile DNA origami tem-
plate (Figure 14b). The probes used in this platform induce the
rearrangement of the 2D or 3D origami nanostructure upon
binding of a target molecule and can be monitored in real time
using optical tweezers. This proof-of-concept study demon-
strates the ability of this platform to detect the platelet-derived
growth factor at 10 pM and to diﬀerentiate it from a DNA target
in a multiplexing fashion.66b The development of a versatile
DNA origami nanoassembly is expected to overcome the
restriction of sensing events that are carried out one at a time
and oﬀers a much-needed solution for high-throughput sensing
at the single-molecule level. A novel chemically modiﬁed
H-shaped DNA oligonucleotide was designed and synthesized
via cross-linking with a structurally rigid linker consisting of
phenylene and ethynylene groups, to construct a rotatable DNA
unit with two complementary DNA oligonucleotides. This
novel rotatory DNA unit may serve as an eﬀective component
of large DNA machines (Figure 14c).66c We designed and con-
structed a transcription-regulation platform in which speciﬁc
DNA strands induced the opening of the six-helix bundled
tubular structure using the toehold system (Figure 14d). The
addition of speciﬁc DNA strands successfully released a tran-
scription product from the puriﬁed tube-attached dsDNA tem-
plate, which suggests the use of a nanostructure that is capable
of acquiring vital mechanistic information.66d
The photo-cross-linking of 8-methoxypsoralen improved the
thermal stability of DNA origami structures. This temperature-
assisted cross-linking was used to assemble and disassemble
origami at higher and lower temperatures, respectively.67a The
introduction of photoresponsive DNAs into hexagonal DNA
origami structures yielded exclusive patterns of multidirec-
tional-programmed 2D DNA nanostructures via irradiation at
diﬀerent wavelengths in a programmed manner. Alterations of
the number and position of photoresponsive DNAs in the
hexagonal units produced speciﬁc face-controlling nanostruc-
tures that facilitated the construction of curved and ring-shaped
nanostructures.67b We introduced cholesterol moieties into the
hexagonal origami structures; the outer edges of one of these
structures carries Azo-ODNs. This assembled bilayer-placed
hexagonal dimer was disassembled into monomer units and
reversibly reassembled under UV irradiation and visible-
light irradiation, respectively. These dynamic assembly/dis-
assembly processes were directly visualized using HS-AFM
(Figure 14e).67c A square bipyramidal DNA nanocapsule (NC)
with a photocontrollable open/close system and a toehold sys-
tem was designed as a nanomaterial carrier. The hybridization
of a speciﬁc DNA (capture strand) facilitated the encapsulation
of the DNA-modiﬁed gold nanoparticle (AuNP) into the NC.
The addition of a toehold-containing complementary DNA
(release strand) successfully released the AuNP from the NC
(Figure 14f ).67d We devised a light-driven artiﬁcial molecular
nanomachine with the aim of introducing cargo transport and
manual conﬁguration alterations in mesoscopic systems. A
walker­stator duplex was designed in which the walker (i.e., a
single-stranded DNA that carried two pyrene molecules) was
located on the surface of the DNA tile, which was assem-
bled using a 2D DNA tile that carried four stator strands as
the linear track. Via the excitation of the pyrene molecules
(­ex = 350 nm), the walker induced the cleavage of disulﬁde
bonds in stator strands and initiated the continuous migra-
tion of the DNA walker from one cleaved stator to the next
intact stator, until it reached the ﬁnal stator. The light-fuelled
movements of this light-driven nanomachine were directly
observed in real time under UV irradiation using HS-AFM
(Figure 14g).67e
We designed and developed diﬀerent kinds of DNA
assemblies with polypod-like and Takumi-shaped structures
as eﬀective nanovehicles for the delivery of immunomodulat-
ing nucleic acids to immune cells.68 RNA­protein complexes
with diﬀerent shapes were engineered for imaging and thera-
peutic applications.69 We constructed “lipid-bilayer-assisted
self-assembly” structures in which DNA origami nanostruc-
tures assembled into 2D lattices. We used mica-supported
zwitterionic lipid bilayers to absorb DNA origami structures
electrostatically in the presence of divalent cations. These
origami units are mobile on the surface and can self-assemble
into large lattices (with a μm size in lateral dimensions)
(Figure 14h). HS-AFM revealed the dynamic processes, such
as growth and reorganization, of lattices. The in situ decoration
of the assembled lattices hinted at the scope of surface modi-
ﬁcation. This new strategy represents a signiﬁcant advancement
in the design and fabrication of novel supermolecular archi-
tectures and in the organization of functional nanodevices (in
μm space).70 In addition, we were able to mimic the dynamic
assembly of membrane-associated protein clusters that play an
essential role in the formation of cellular membranes.
5. DNA-Based Systems for Practical Applications
5.1 Design of DNA-Based Switching Devices. Because
topologically interesting molecular architectures, such as cate-
nanes, display unique physical properties, strategies aimed at
constructing such architectures are of great interest. We devel-
oped a novel strategy to synthesize a heat-resistant DNA
catenane using the formation of a G-quadruplex structure via
the cyclization of DNA through the covalent bond connec-
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tion.71 To advance the application of long ﬂuorescent DNAs,
we synthesized a highly emissive thioanalogue of thdGTP and
enzymatically incorporated it into DNA via primer extension
and PCR ampliﬁcation. The synthesized 2-aminothieno[3,4-d]-
pyrimidine G-mimic deoxyribonucleoside (thdG)-labeled DNA
was ampliﬁed by natural polymerases and thdGTP was added
to the standard PCR mix in a straightforward manner.72a
Subsequently, we incorporated thdG readily into oligo-
nucleotides and demonstrated that Z-DNA was successfully
detected based on the diﬀerent π-stacking properties of B- and
Z-DNA.72b As an analogue of thdG, 2¤-OMe-thdG, eﬀectively
induced Z-form DNA, we constructed a visible nanothermom-
eter based on the B­Z transition of DNA.72c We synthesized
various oligomers of d(CG)n or d(GC)n containing 8-methyl-
guanine at a diﬀerent position. CD spectra studies showed that
the order of arrangement of m(8)G and m(8)rG in DNA strands
inﬂuenced the Z-DNA stabilizing eﬀect and that the center posi-
tion eﬀectively stabilized and promoted the B­Z transition.72d
5.2 Development of DNA as a Catalyst for Organic
Synthesis. There is increasing demand for the development
Figure 15. DNA-based hybrid catalyst. Illustration of a) L-Cu(II)-R/DNA catalyzed unimolecular Friedel­Crafts reaction
(Reproduced from Petrova et al.73b). b) DNA-based hybrid catalyst with an intramolecular ligand (Reproduced from Park et al.73c).
c) Solid-supported DNA used for asymmetric synthesis (Reproduced from Park et al.74a). d) Rational design approach for
the development of nature-inspired DNA metalloenzymes that are capable of catalyzing asymmetric Diels­Alder reactions
(Reproduced from Park et al.74b).
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of eﬃcient synthetic strategies that are economical and eco-
friendly in the ﬁeld of production of pharmaceuticals and agro-
chemicals. For this purpose, the synthesis of enantiomerically
pure compounds using stereoselective hybrid systems is an
attractive approach. However, most methods rely primarily on
the use of enzymes, proteins, or RNA. DNA hybrid catalysis
is a promising alternative because of the unique chirality of
DNA and its capability to inﬂuence the stereochemical course
of a reaction. Moreover, DNA-based catalytic systems can
be used in aqueous media. DNA-based hybrid catalysts that
self-assemble from DNA and a metal complex with a speciﬁc
ligand using supramolecular or covalent anchoring strategies
have high stereoselectivity and exhibit rate enhancement in
Lewis acid catalyzed reactions, such as Diels­Alder, Michael
addition, and Friedel­Crafts reactions.73 However, despite a
number of reports on the enantioselectivity of the reactions
originated from DNA, the mechanism underlying stereoinduc-
tion remains poorly understood. Therefore, we used an intra-
molecular reaction as a suitable system to investigate the
stereoinduction mechanism underlying DNA-based asymmetric
synthesis, as it signiﬁcantly reduces conformational freedom.
Moreover, the Friedel­Crafts reaction was used as a model for
the intramolecular reaction. We then deciphered DNA-based
asymmetric catalysis through intramolecular Friedel­Crafts
alkylation and proposed a plausible binding model and (S)-
enantiomer complex with Cu(5,6-dmp) based on the inter-
calation.73a We carried out computational studies to investi-
gate the origin of the enantioselectivity of the intramolecular
Friedel­Crafts reaction, which is catalyzed by a supramolecular
Cu/DNA catalyst (Figure 15a).
We modeled 28 conformations of the supramolecular L-
Cu(II)-R/d(CAAAAATTTTTG)2 complex and evaluated their
stability and structural features according to the metal complex
conformation and its intercalation position.73b The results sug-
gested that S-product selectivity is caused by the higher binding
energy of the pro-S conformation. Furthermore, the pro-S con-
formation appeared to be structurally closer to the TS of C3­
C2¤ bond formation. Consequently, we devised an advanced
DNA-based hybrid catalyst based on the direct incorporation of
a ligand into the DNA phosphate backbone. We successfully
performed asymmetric intramolecular Friedel­Crafts alkyla-
tions using the developed DNA-based hybrid catalyst contain-
ing an intrastrand bipyridine (Figure 15b). Further investiga-
tion of the structural details of DNA hybrid catalysts via the
generation of a series of active site showed that the catalytic
properties are managed by (i) the disposition of the metal-
binding site in the DNA duplex, (ii) the size of catalytic cavity,
and (iii) the composition of nucleobases in the catalytic pocket.
An aﬀordable and easy-to-prepare solid-supported DNA
system termed st-DNA/S1 was developed. We successfully
carried out the Diels­Alder reaction and demonstrated that this
system could be reused readily for 10 cycles (Figure 15c).74a
This ﬁrst-ever report of the development of a solid-supported
DNA system may contribute as a valuable stepping-stone for
the industrial application of DNA-based asymmetric synthe-
sis, such as a continuous ﬂow system. Inspired by the superior
characteristics of the naturally occurring metalloenzymes in
catalyzing biologically essential chemical reactions, we devel-
oped DNA metalloenzymes that combine metal-assisted cataly-
sis with a chiral biomacromolecule. Using our DNA metal-
loenzymes, we successfully catalyzed asymmetric Diels­Alder
reactions with high conversion, excellent endo/exo selectiv-
ity, and enantioselectivity up to ¹97% ee. These DNA metal-
loenzymes were prepared using a rational design strategy based
on the Cu(II) ion, to organize the catalytic-pocket architectures,
the composition of nucleobases, and the incorporation of ﬂexi-
ble linkers (Figure 15d).74b
Interestingly, the DNA metalloenzymes aﬀorded the oppo-
site enantiomer of the Diels­Alder product compared with
those obtained using a supramolecular Cu(II)­dmbpy/st­DNA
catalyst system. This strategy allowed development of artiﬁ-
cial metalloenzymes without the incorporation of an artiﬁcial
binding ligand and obviated the conventional protein­metallo-
enzyme complexes, thus providing a new outlook on the
harnessing of the catalytic repertoire of nucleic acids.
6. Summary and Outlook
There is a growing demand for the development of next-
generation biomaterials that are capable of overcoming current
economic, clinical and eﬃciency issues. A closer look at the
natural cellular environment may inspire the development of
novel biomaterials that are useful for humankind. We have
been making steadfast progress toward the use of the chemi-
cal biology of nucleic acids to design and construct nature-
inspired smart biomaterials. Recent high-throughput sequenc-
ing technologies have aided the identiﬁcation of critical DNA
sequences and their association with key transcription factors
(TFs) that govern the expression of therapeutically important
and cell-fate-governing genes. We have successfully mimicked
natural TFs encompassing functional domains (repressor or
activator domains) and DNA-binding domains (DBDs) to
construct synthetic transcription factors. Pyrrole-imidazole
polyamides (PIPs) mimicked the DBD and were capable of
selectively altering the expression of therapeutically important
genes, such as EVI1. We supplemented PIPs with DNA-
alkylating agents to mimic the repressor domain of TFs and
showed the site-selective repression of several oncogenes, such
as KRAS. To mimic the activation domain, we conjugated
PIPs with epigenetic activators such as SAHA and CTB. PIPs
conjugated with ﬂuorophores were used to recognize human
telomeric DNA selectively. The functional components of arti-
ﬁcial TFs were successfully altered with substantial tunability.
Our collaborative studies demonstrated the pharmacokinetic
properties of PIPs, suggesting the possibility of developing
these artiﬁcial TFs as drugs. Next-generation sequencing stud-
ies guided the construction of advanced PIPs. We carried out
mechanistic investigations to obtain a broader understanding
of the structural and molecular recognition properties of bio-
logically signiﬁcant DNA conformational changes, such as
G-quadruplex formation and Z-DNA formation. In particular,
we proposed a new folding pathway leading to G-quadruplex
formation. We also developed photoproducts that mirrored the
nucleic acid local structure, to probe conformational changes at
sequence resolution during irradiation. Because of its program-
mable self-assembling feature and precise recognition ability,
DNA also represents an exceptional working material. We
harnessed the DNA self-assembly system to visualize single-
molecule interactions, conformational changes, and chemical/
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enzymatic reactions in a mimicked nanospace. We achieved an
innovatively programmed assembly of nanostructures with dif-
ferent dimensions, to mimic the intricate structures observed in
nature. We also constructed molecular nanosystems and nano-
devices with versatile biological applications and developed
DNA-based switching devices, such as the visible thermom-
eter. An eﬃcient DNA-based hybrid biocatalyst was also
developed to perform asymmetric Diels­Alder and Friedel­
Crafts reactions. In particular, we developed nature-inspired
DNA metalloenzymes that are capable of catalyzing useful
chemical reactions.
In summary, we have successfully mimicked nucleic acid
and molecular components occurring in the natural cellular
environment and have constructed DNA-based transcription
factors, monitor systems, functional nanosystems/nanodevices
and hybrid biocatalyst for versatile uses (Figure 16). Modern
proﬁling and analytical techniques aid to attain detailed infor-
mation about the nucleic acid structures that are observed in the
natural cellular environment and devise innovative strategies
to construct smart biomaterials for versatile applications.
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